An Open Label Multi-Dose Study to Examine the Effect of Coated Nifedipine Suppository on Anal Fissure Pain and Healing
Status:
Terminated
Trial end date:
2015-11-01
Target enrollment:
Participant gender:
Summary
This is an open label study. The study will consist of 2 treatment group: coated Nifedipine
suppository containing 12 mg of Nifedipine applied twice daily (group 1) and coated
Nifedipine suppository containing 12 mg of Nifedipine applied once daily (group 2).
Approximately 30 subjects will participate into this 8-week study. The primary objective is
to examine the dose effect of coated Nifedipine suppository on Anal fissure pain and healing.